Phase 1 Myeloma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are willing to take part and have given your written agreement to join the study
- You are between 18 and 75 years old (any gender)
- Your doctor estimates you are likely to live for at least 12 weeks
- You are reasonably active and able to care for yourself, with limited or no restrictions on daily activities (confirm with trial site)
- You have been diagnosed with multiple myeloma based on recognised international guidelines
- You have already received at least 3 different types of treatment for multiple myeloma, including specific drug types (proteasome inhibitors, immunomodulatory agents, and a CD38 antibody), and your disease has come back or stopped responding to treatment
- If you are a woman who could become pregnant, you have a negative pregnancy test before starting and agree to use effective birth control throughout the trial
- Your blood test results meet minimum required levels for certain blood cells (confirm specific values with trial site)
Who may not be able to join:
- You have a history of serious head injury, loss of consciousness, epilepsy/seizures, or bleeding or blockages in the brain
- You have a history of serious heart conditions, including an abnormal heart rhythm or a specific irregular electrical signal in the heart (confirm with trial site)
- You are currently pregnant or breastfeeding
- You have HIV
- You currently have an active hepatitis B or hepatitis C infection
- You have been taking steroid tablets or injections (not inhalers) in the 2 weeks before joining the study
- Your immune cells do not respond well enough to a specific laboratory test (confirm with trial site)
- Your kidney or liver function blood tests are above certain levels (confirm specific values with trial site)
- You have another cancer that is not under control, unless it was fully treated with no signs of disease in the past 3 years
- You received a stem cell transplant using your own cells within 8 weeks before joining, or plan to have one during the study
- You have ever received a stem cell transplant using someone else's cells
- You received cancer treatment or certain other medications within 2 weeks before joining
- The trial doctor believes there is any other reason that joining would not be safe or suitable for you
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: He Huang, MD, Zhejiang University
Phone: 86-13605714822
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Dose-limiting toxicity (DLT); Incidence of treatment-emergent adverse events (TEAEs)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.